Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1968 1
1969 1
1971 1
1972 1
1974 1
1977 1
1978 1
1979 1
1980 1
1981 2
1982 5
1983 5
1984 1
1985 6
1986 3
1987 7
1988 4
1989 6
1990 4
1991 2
1992 2
1993 4
1994 2
1995 1
1996 3
1997 5
1998 9
1999 7
2000 11
2001 6
2002 8
2003 7
2004 9
2005 8
2006 8
2007 5
2008 9
2009 7
2010 9
2011 10
2012 9
2013 11
2014 8
2015 12
2016 13
2017 12
2018 14
2019 15
2020 36
2021 25
2022 37
2023 20
2024 30
2025 32
2026 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

437 results

Results by year

Filters applied: . Clear all
Page 1
A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma.
Fushimi C, Tada Y, Takahashi H, Nagao T, Ojiri H, Masubuchi T, Matsuki T, Miura K, Kawakita D, Hirai H, Hoshino E, Kamata S, Saotome T. Fushimi C, et al. Among authors: matsuki t. Ann Oncol. 2018 Apr 1;29(4):979-984. doi: 10.1093/annonc/mdx771. Ann Oncol. 2018. PMID: 29211833 Free PMC article. Clinical Trial.
Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma.
Takahashi H, Tada Y, Saotome T, Akazawa K, Ojiri H, Fushimi C, Masubuchi T, Matsuki T, Tani K, Osamura RY, Hirai H, Yamada S, Kawakita D, Miura K, Kamata SE, Nagao T. Takahashi H, et al. Among authors: matsuki t. J Clin Oncol. 2019 Jan 10;37(2):125-134. doi: 10.1200/JCO.18.00545. Epub 2018 Nov 19. J Clin Oncol. 2019. PMID: 30452336 Clinical Trial.
Variability of macrolide-resistant profile in Mycobacterium avium complex pulmonary disease.
Fukushima K, Matsumoto Y, Abe Y, Hashimoto K, Motooka D, Kitada S, Saito H, Komukai S, Fukui E, Niitsu T, Nabeshima H, Nagahama Y, Yamauchi J, Nitta T, Nii T, Matsuki T, Tsujino K, Miki K, Shintani Y, Kumanogoh A, Akira S, Nakamura S, Kida H. Fukushima K, et al. Among authors: matsuki t. Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0121324. doi: 10.1128/aac.01213-24. Epub 2024 Oct 8. Antimicrob Agents Chemother. 2024. PMID: 39377582 Free PMC article.
Serum vesicle biomarkers reflect the disease activity of idiopathic pulmonary fibrosis.
Shirai Y, Enomoto T, Takeda Y, Edahiro R, Takahashi-Itoh M, Noda Y, Adachi Y, Nakayama M, Kawasaki T, Koba T, Futami Y, Yoshimura H, Amiya S, Hara R, Yamamoto M, Nakatsubo D, Suga Y, Naito M, Masuhiro K, Matsuki T, Hirata H, Iwahori K, Nagatomo I, Miyake K, Koyama S, Fukushima K, Shiroyama T, Naito Y, Futami S, Natsume-Kitatani Y, Ose N, Funaki S, Nojima S, Shichino S, Yanagawa M, Shintani Y, Nogami-Itoh M, Adachi J, Inoue Y, Tomonaga T, Okada Y, Mizuguchi K, Kumanogoh A. Shirai Y, et al. Among authors: matsuki t. J Transl Med. 2025 Oct 15;23(1):1102. doi: 10.1186/s12967-025-07011-2. J Transl Med. 2025. PMID: 41094533 Free PMC article.
Identification of risk loci for postpartum depression in a genome-wide association study.
Li X, Takahashi N, Narita A, Nakamura Y, Sakurai-Yageta M, Murakami K, Ishikuro M, Obara T, Kikuya M, Ueno F, Metoki H, Ohseto H, Takahashi I, Nakamura T, Warita N, Shoji T, Yu Z, Ono C, Kobayashi N, Kikuchi S, Matsuki T, Nagami F, Ogishima S, Sugawara J, Hoshiai T, Saito M, Fuse N, Kinoshita K, Yamamoto M, Yaegashi N, Ozaki N, Tamiya G, Kuriyama S, Tomita H. Li X, et al. Among authors: matsuki t. Psychiatry Clin Neurosci. 2024 Nov;78(11):712-720. doi: 10.1111/pcn.13731. Epub 2024 Sep 17. Psychiatry Clin Neurosci. 2024. PMID: 39287932 Free PMC article.
The impact of HER2-Low expression in salivary duct carcinoma: Clinicopathologic features, survival outcomes, and association with androgen receptor-targeted therapy.
Kano S, Kawakita D, Honma Y, Takahashi H, Nakaguro M, Utsumi Y, Saigusa N, Hanazawa T, Tsukahara K, Okada T, Okami K, Yamazaki K, Ueki Y, Saito Y, Ozawa H, Arai T, Shimizu A, Hanyu K, Iwaki S, Imaizumi S, Sakai A, Yamauchi M, Tanaka R, Sato Y, Yamamura K, Sekimizu M, Imanishi Y, Hirai H, Sato Y, Urano M, Yamamoto H, Fushimi C, Matsuki T, Nagao T, Tada Y; Multi-institutional Joint SDC Study Group in Japan. Kano S, et al. Among authors: matsuki t. Oral Oncol. 2025 Jun;165:107280. doi: 10.1016/j.oraloncology.2025.107280. Epub 2025 Apr 18. Oral Oncol. 2025. PMID: 40252453 Free article.
Molecular epidemiological surveillance for non-tuberculous mycobacterial pulmonary disease: a single-center prospective cohort study.
Hashimoto K, Fukushima K, Matsumoto Y, Saito H, Funauchi A, Hamada N, Niitsu T, Abe Y, Yamauchi J, Nitta T, Motooka D, Nii T, Matsuki T, Tsujino K, Miki K, Kumanogoh A, Nakamura S, Kida H. Hashimoto K, et al. Among authors: matsuki t. Microbiol Spectr. 2025 Oct 7;13(10):e0043625. doi: 10.1128/spectrum.00436-25. Epub 2025 Aug 21. Microbiol Spectr. 2025. PMID: 40838858 Free PMC article.
Cytoplasmic p53 Immunostaining in Salivary Duct Carcinoma: A Poor Prognostic Factor Associated With Characteristic TP53 Variants.
Utsumi Y, Nakaguro M, Kawakita D, Hirai H, Sukeda A, Kohsaka S, Tsukahara K, Hanazawa T, Kano S, Yamazaki K, Ueki Y, Okami K, Saito Y, Ozawa H, Honma Y, Shimizu A, Hanyu K, Fujii S, Arai T, Iwaki S, Imaizumi S, Tanaka R, Yamauchi M, Yamamura K, Sekimizu M, Takahashi H, Imanishi Y, Sato Y, Matsuki T, Tada Y, Nagao T; Multi-institutional Joint SDC Study Group in Japan. Utsumi Y, et al. Among authors: matsuki t. Mod Pathol. 2025 Jul;38(7):100766. doi: 10.1016/j.modpat.2025.100766. Epub 2025 Apr 7. Mod Pathol. 2025. PMID: 40204093
437 results